Detalhe da pesquisa
1.
NFκB and TGFß contribute to the expression of PTPN3 in activated human lymphocytes.
Cell Immunol
; 358: 104237, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33137650
2.
Risk factors for sodium valproate-induced renal tubular dysfunction.
Clin Exp Nephrol
; 22(2): 420-425, 2018 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-28836089
3.
[Plication for Diaphragmatic Eventration by Complete Video-assisted Thoracoscopic].
Kyobu Geka
; 71(3): 173-177, 2018 Mar.
Artigo
em Japonês
| MEDLINE | ID: mdl-29755069
4.
Inhibition of PTPN3 Expressed in Activated Lymphocytes Enhances the Antitumor Effects of Anti-PD-1 Therapy in Head and Neck Cancer, Especially in Hypoxic Environments.
J Immunother
; 47(3): 89-97, 2024 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38297883
5.
PTPN3 inhibition contributes to the activation of the dendritic cell function to be a promising new immunotherapy target.
J Cancer Res Clin Oncol
; 149(16): 14619-14630, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37584709
6.
MAML3 Contributes to Induction of Malignant Phenotype of Gallbladder Cancer Through Morphogenesis Signalling Under Hypoxia.
Anticancer Res
; 43(7): 2909-2922, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-37351966
7.
C4orf47 contributes to the dormancy of pancreatic cancer under hypoxic conditions.
J Cancer
; 14(2): 306-317, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36741255
8.
Calcium/calmodulin-dependent kinase inhibitor induces growth inhibition, cell cycle arrest, and apoptosis in human choriocarcinoma cells.
Tumour Biol
; 33(4): 1053-8, 2012 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-22290426
9.
A translocator protein ligand PK11195 shows antigrowth activity in human choriocarcinoma cells.
Tumour Biol
; 33(5): 1505-10, 2012 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-22528948
10.
The vitamin E derivative, EPC-K1, suppresses inflammation during hepatic ischemia-reperfusion injury and exerts hepatoprotective effects in rats.
J Surg Res
; 176(1): 164-70, 2012 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-22560539
11.
Advanced lung adenocarcinoma detected by choroidal metastasis in a patient with amyopathic dermatomyositis: A case report.
Thorac Cancer
; 13(11): 1739-1743, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35451568
12.
PTPN3 Could Βe a Therapeutic Target of Pancreatic Cancer.
Anticancer Res
; 42(6): 2869-2874, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-35641270
13.
[Control of postoperative nausea and vomiting by preventive administration of dexamethasone].
Masui
; 60(6): 677-81, 2011 Jun.
Artigo
em Japonês
| MEDLINE | ID: mdl-21710761
14.
GLI2 but not GLI1/GLI3 plays a central role in the induction of malignant phenotype of gallbladder cancer.
Oncol Rep
; 45(3): 997-1010, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33650666
15.
PTPN3 is a potential target for a new cancer immunotherapy that has a dual effect of T cell activation and direct cancer inhibition in lung neuroendocrine tumor.
Transl Oncol
; 14(9): 101152, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-34134073
16.
Patched 1-interacting Peptide Represses Fibrosis in Pancreatic Cancer to Augment the Effectiveness of Immunotherapy.
J Immunother
; 43(4): 121-133, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31834207
17.
FAM115C could be a novel tumor suppressor associated with prolonged survival in pancreatic cancer patients.
J Cancer
; 11(8): 2289-2302, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32127956
18.
[The effect of operating time of PMX-DHP on decrease of platelets].
Masui
; 57(8): 948-52, 2008 Aug.
Artigo
em Japonês
| MEDLINE | ID: mdl-18709997
19.
Successful Surgical Resection following Bronchial Artery Embolization in a Case of Lung Cancer Complicated with Massive Hemoptysis.
Case Rep Oncol
; 11(1): 125-130, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29606951
20.
Corrigendum to "PTPN3 is a potential target for a new cancer immunotherapy that has a dual effect of T cell activation and direct cancer inhibition in lung neuroendocrine tumor" [Volume 14, Issue 9, September 2021, 101152].
Transl Oncol
; 17: 101344, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-35042060